Skip to main content

Pathobiont-triggered induction of goblet cell response drives regional susceptibility to inflammatory bowel disease.

Publication ,  Journal Article
Spencer, PN; Brown, ME; Smith, EP; Wang, J; Kim, W; Spiga, L; Tasneem, N; Simmons, AJ; Kim, T; Yang, Y; Xu, Y; Zheng, L; Ro, J; Kaur, H ...
Published in: J Clin Invest
April 1, 2026

The gastrointestinal tract varies in structure and function by region, yet the drivers of region-specific inflammatory disease remain elusive. Here, a TNF-overexpressing murine model (TnfΔARE/+) of Crohn's disease (CD) was used to investigate how pathobionts interact with host immune susceptibilities to drive region-specific disease. We identified the pathobiont Chlamydia muridarum, an intracellular bacterium and murine counterpart to the human sexually transmitted C. trachomatis, as a necessary and sufficient trigger for disease manifestation in the proximal/ascending colon, a common site of CD. In genetically susceptible hosts, pathobiont-triggered proximal colonic inflammation is driven by goblet cell responses, including tryptophan metabolism via indoleamine 2,3-dioxygenase 1 (IDO1). Our findings translate to human disease, where we demonstrate upregulation of epithelia-derived IDO1 in actively inflamed ascending colon specimens, but not actively inflamed terminal ileum specimens, of patients with CD. Our findings mechanistically reveal how genetic and microbial factors drive the manifestation of disease in a region-specific manner and provide a unique model to study CD specific to the ascending colon.

Duke Scholars

Published In

J Clin Invest

DOI

EISSN

1558-8238

Publication Date

April 1, 2026

Volume

136

Issue

7

Location

United States

Related Subject Headings

  • Mice, Transgenic
  • Mice
  • Male
  • Inflammatory Bowel Diseases
  • Indoleamine-Pyrrole 2,3,-Dioxygenase
  • Immunology
  • Humans
  • Goblet Cells
  • Female
  • Disease Susceptibility
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Spencer, P. N., Brown, M. E., Smith, E. P., Wang, J., Kim, W., Spiga, L., … Lau, K. S. (2026). Pathobiont-triggered induction of goblet cell response drives regional susceptibility to inflammatory bowel disease. J Clin Invest, 136(7). https://doi.org/10.1172/JCI201729
Spencer, Paige N., Monica E. Brown, Erin P. Smith, Jiawei Wang, William Kim, Luisella Spiga, Naila Tasneem, et al. “Pathobiont-triggered induction of goblet cell response drives regional susceptibility to inflammatory bowel disease.J Clin Invest 136, no. 7 (April 1, 2026). https://doi.org/10.1172/JCI201729.
Spencer PN, Brown ME, Smith EP, Wang J, Kim W, Spiga L, et al. Pathobiont-triggered induction of goblet cell response drives regional susceptibility to inflammatory bowel disease. J Clin Invest. 2026 Apr 1;136(7).
Spencer, Paige N., et al. “Pathobiont-triggered induction of goblet cell response drives regional susceptibility to inflammatory bowel disease.J Clin Invest, vol. 136, no. 7, Apr. 2026. Pubmed, doi:10.1172/JCI201729.
Spencer PN, Brown ME, Smith EP, Wang J, Kim W, Spiga L, Tasneem N, Simmons AJ, Kim T, Yang Y, Xu Y, Zheng L, Ro J, Kaur H, Kang SW, Helou MD, Lee MA, Arceneaux D, Mueller KD, Kuddar OS, Harned MH, Li J, Banerjee A, Markham NO, Wilson KT, Coburn LA, Goettel JA, Liu Q, Washington MK, Valdivia RH, Zhu W, Lau KS. Pathobiont-triggered induction of goblet cell response drives regional susceptibility to inflammatory bowel disease. J Clin Invest. 2026 Apr 1;136(7).

Published In

J Clin Invest

DOI

EISSN

1558-8238

Publication Date

April 1, 2026

Volume

136

Issue

7

Location

United States

Related Subject Headings

  • Mice, Transgenic
  • Mice
  • Male
  • Inflammatory Bowel Diseases
  • Indoleamine-Pyrrole 2,3,-Dioxygenase
  • Immunology
  • Humans
  • Goblet Cells
  • Female
  • Disease Susceptibility